Natco Pharma launches higher strength Anti Cancer generic drug

The drug is used in the treatment of certain cancer. USFDA had previously granted final approval for this ANDA.

89
Medicine Tablets
Picture: Pixabay

Last Updated on October 5, 2021 by The Health Master

Natco Pharma on Friday said marketing partner Breckenridge Pharmaceutical Inc. has launched 10 mg strength of Everolimus Tablets (generic for Afinitor) in the US market.

The drug is used in the treatment of certain cancer. USFDA had previously granted final approval for this ANDA.

The 10mg strength of Afinitor had generated annual sales of $392 million during the twelve months ending July 2021, it said citing industry sales data.

Breckenridge launched Everolimus tablets 2.5mg, 5mg and 7.5mg strengths during the first quarter of 2021 in the US., the company said in a release.

Lupin launches Droxidopa capsules

Sun Pharma launches a novel formulation for Cough management

Lincoln Pharma plans to launch Cephalosporin products

Natural Antioxidant Gamma Oryzanol launched in India

Dr. Reddy’s Labs launches Rx drug Minoxidil for treatment of hair

Dr Reddy’s launches Reddy-Lenalidomide

Woman held for selling fake Cancer Drugs

FDA advisers to review C-19 shots for young kids

New drug combination found effective against C-19 infection: Study

Drug recall: Auro Pharma recalls Drug used to treat severe disease

Govt to introduce needle free Vaccine shortly

Latest Notifications regarding Pharmaceuticals

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner